Montis Financial’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Montis Financial’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,549	Closed	-$207K	–	145
2025 Q1	$207K	Hold	2,549	–	–	0.06%	140
2024 Q4	$230K	Hold	2,549	–	–	0.07%	125
2024 Q3	$252K	Hold	2,549	–	–	0.09%	97
2024 Q2	$236K	Hold	2,549	–	–	0.11%	72
2024 Q1	$242K	Hold	2,549	–	–	0.11%	75
2023 Q4	$228K	Buy	+2,549	New	+$189K	0.14%	68
2023 Q3	–	Sell	-2,699	Closed	-$225K	–	75
2023 Q2	$225K	Hold	2,699	–	–	0.15%	57
2023 Q1	$206K	Sell	2,699 -12	-0.4%	-$996	0.16%	58
2022 Q4	$225K	Sell	2,711 -2,935	-52%	-$238K	0.19%	56
2022 Q3	$448K	Hold	5,646	–	–	0.43%	33
2022 Q2	$419K	Buy	5,646 +1,494	+36%	+$112K	0.39%	34
2022 Q1	$373K	Buy	4,152 +1,615	+64%	+$149K	0.29%	38
2021 Q4	$284K	Hold	2,537	–	–	0.21%	58
2021 Q3	$313K	Sell	2,537 -433	-15%	-$55.8K	0.27%	39
2021 Q2	$402K	Buy	2,970 +1,044	+54%	+$137K	0.33%	41
2021 Q1	$264K	Hold	1,926	–	–	0.25%	54
2020 Q4	$293K	Buy	+1,926	New	+$247K	0.29%	48

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Montis Financial's XBI Position: Q2 2025 in Review

Montis Financial sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 2,549 shares — an estimated $207K sold.

Montis Financial first reported a position in XBI in Q4 2020 and held it in 17 quarters. The position peaked at $448K in Q3 2022. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Montis Financial reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Montis Financial sold 2,549 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $207K.
Montis Financial first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 17 quarters.
Montis Financial's State Street SPDR S&P Biotech ETF position peaked at $448K in Q3 2022.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Montis Financial's 13F filing for Q2 2025, filed 17 Jul 2025.